Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 22,273	$ 106,374
Accounts receivable:
Trade	40,718	19,425
Other, net	16,218	13,691
Inventories:
Product inventories	34,807	28,823
Materials and supplies	69,721	64,824
Other current assets	22,230	27,125
Total current assets	205,967	260,262
Investments	42,019	33,724
Restricted cash and cash equivalents	1,184	1,165
Property, plant and mine development, net	2,665,342	2,666,250
Operating lease right-of-use assets	5,173	8,349
Deferred tax assets	0	2,883
Other non-current assets	36,026	38,471
Total assets	2,955,711	3,011,104
Current liabilities:
Accounts payable and accrued liabilities	86,976	81,599
Accrued payroll and related benefits	26,447	28,240
Accrued taxes	4,563	3,501
Current debt	35,874	0
Finance leases	7,299	9,752
Accrued reclamation and closure costs	10,261	9,660
Accrued interest	5,192	14,405
Other current liabilities	11,960	10,303
Total current liabilities	188,572	157,460
Accrued reclamation and closure costs	108,329	110,797
Long-term debt including finance leases	496,631	653,063
Deferred tax liabilities	111,331	104,835
Other non-current liabilities	12,566	16,845
Total liabilities	917,429	1,043,000
Commitments and contingencies (Notes 4, 7, 8, and 11)
STOCKHOLDERS' EQUITY
Series B preferred stock, $0.25 par value, 157,776 shares issued and outstanding, liquidation preference - $7,889	39	39
Common stock, $0.25 par value, authorized 750,000,000 shares; issued September 30, 2024 - 637,078,901 shares and December 31, 2023 - 624,647,379 shares	159,185	156,076
Capital surplus	2,413,546	2,343,747
Accumulated deficit	(496,674)	(503,861)
Accumulated other comprehensive income (loss), net	(2,883)	5,837
Less treasury stock, at cost; September 30, 2024 - 8,813,127 and December 31, 2023 - 8,535,161 shares issued and held in treasury	(34,931)	(33,734)
Total stockholders' equity	2,038,282	1,968,104
Total liabilities and stockholders' equity	$ 2,955,711	$ 3,011,104